Search
for
Sort by
Research 121–150 of 1000+
- 467 Novel selective phosphodiesterase inhibitors promote the adipogenic function of dermal fibroblasts: Implication to treat hair loss
- The Modulation of Aromatase and Estrogen Receptor Alpha in Cultured Human Dermal Papilla Cells by Dexamethasone: A Novel Mechanism for Selective Action of Estrogen via Estrogen Receptor Beta?
- Baicalin inhibits recruitment of GATA1 to the HSD3B2 promoter and reverses hyperandrogenism of PCOS
- HPLC characterization, molecular docking, QSAR and molecular dynamics simulation of Alstonia boonei phytochemical analogs as potent 5-alpha reductase inhibitors
- Safety and quality of life of CDK4/6 inhibitors therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: a multicenter cross-sectional survey in China
- Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- 9 Role of 5α-reductase in health and disease
- Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases
- Idiopathic Hirsutism*
- 17β-Estradiol Inhibits Wound Healing in Male Mice via Estrogen Receptor-α
- Hormone therapy in acne
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Hirsutism, postpartum telogen effluvium, and male pattern alopecia
- Antiandrogen therapy for androgenetic alopecia
- Alopecia - the search for novel agents continues
- Effect of finasteride on the ovulatory function of normal women
- Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson’s Disease Models
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Androgenetic alopecia, hirsutism and hypertrichosis
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- Female Pattern Hair Loss
- Early embryonic exposure of freshwater gastropods to pharmaceutical 5-alpha-reductase inhibitors results in a surprising open-coiled “banana-shaped” shell
- Anti-androgenic curcumin analogues as steroid 5-alpha reductase inhibitors
- Physiology and Medical Treatments for Alopecia
- Ficus benghalensis as Potential Inhibitor of 5α-Reductase for Hair Growth Promotion: In Vitro, In Silico, and In Vivo Evaluation
- Pathogenesis of androgenetic alopecia